SOX18 and isolated hemihyperplasia: To further assess the possibility of adrenergic involvement, we tested in the murine model for IH described in Figure 1A the small molecule Sm4, an orally active SOX18 inhibitor that directly disrupts SOX18 interaction with a subset of binding partners (37).